SWTX logo

SpringWorks Therapeutics (SWTX) Cash From Operations

Annual CFO

-$175.60 M
+$47.20 M+21.18%

December 31, 2024


Summary


Performance

SWTX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSWTXcash flowmetrics:

Quarterly CFO

-$29.50 M
-$4.12 M-16.24%

December 31, 2024


Summary


Performance

SWTX Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSWTXcash flowmetrics:

TTM CFO

-$175.60 M
+$33.20 M+15.90%

December 31, 2024


Summary


Performance

SWTX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSWTXcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SWTX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.2%+29.4%+24.9%
3 y3 years-37.3%+29.4%+24.9%
5 y5 years-270.1%+29.4%+24.9%

SWTX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.3%+21.2%-50.5%+62.6%-37.3%+26.8%
5 y5-year-445.5%+21.2%-295.8%+62.6%-445.5%+26.8%
alltimeall time-1139.6%+21.2%-295.8%+62.6%-2346.7%+26.8%

SpringWorks Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$175.60 M(-21.2%)
-$29.50 M(+16.2%)
-$175.60 M(-15.9%)
Sep 2024
-
-$25.38 M(-39.3%)
-$208.80 M(-10.7%)
Jun 2024
-
-$41.79 M(-47.1%)
-$233.89 M(-2.5%)
Mar 2024
-
-$78.93 M(+25.9%)
-$239.91 M(+7.7%)
Dec 2023
-$222.79 M(+37.9%)
-$62.70 M(+24.3%)
-$222.79 M(+4.0%)
Sep 2023
-
-$50.46 M(+5.5%)
-$214.29 M(+16.8%)
Jun 2023
-
-$47.81 M(-22.7%)
-$183.43 M(+5.0%)
Mar 2023
-
-$61.82 M(+14.1%)
-$174.69 M(+8.1%)
Dec 2022
-$161.56 M(+26.3%)
-$54.20 M(+176.5%)
-$161.56 M(+5.1%)
Sep 2022
-
-$19.60 M(-49.8%)
-$153.68 M(-4.5%)
Jun 2022
-
-$39.07 M(-19.8%)
-$161.00 M(+3.6%)
Mar 2022
-
-$48.69 M(+5.1%)
-$155.46 M(+21.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$127.88 M(+297.2%)
-$46.32 M(+72.0%)
-$127.88 M(+92.3%)
Sep 2021
-
-$26.93 M(-19.7%)
-$66.50 M(+22.5%)
Jun 2021
-
-$33.53 M(+58.9%)
-$54.27 M(+47.1%)
Mar 2021
-
-$21.10 M(-240.1%)
-$36.90 M(+14.6%)
Dec 2020
-$32.19 M(-32.1%)
$15.07 M(-202.5%)
-$32.19 M(-49.2%)
Sep 2020
-
-$14.70 M(-9.0%)
-$63.32 M(+6.0%)
Jun 2020
-
-$16.16 M(-1.5%)
-$59.73 M(+5.4%)
Mar 2020
-
-$16.40 M(+2.1%)
-$56.66 M(+19.4%)
Dec 2019
-$47.44 M(+234.9%)
-$16.06 M(+44.5%)
-$47.44 M(+51.2%)
Sep 2019
-
-$11.11 M(-15.1%)
-$31.38 M(+54.8%)
Jun 2019
-
-$13.09 M(+82.4%)
-$20.27 M(+182.4%)
Mar 2019
-
-$7.18 M
-$7.18 M
Dec 2018
-$14.17 M
-
-

FAQ

  • What is SpringWorks Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual CFO year-on-year change?
  • What is SpringWorks Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly CFO year-on-year change?
  • What is SpringWorks Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM CFO year-on-year change?

What is SpringWorks Therapeutics annual cash flow from operations?

The current annual CFO of SWTX is -$175.60 M

What is the all time high annual CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual cash flow from operations is -$14.17 M

What is SpringWorks Therapeutics annual CFO year-on-year change?

Over the past year, SWTX annual cash flow from operations has changed by +$47.20 M (+21.18%)

What is SpringWorks Therapeutics quarterly cash flow from operations?

The current quarterly CFO of SWTX is -$29.50 M

What is the all time high quarterly CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly cash flow from operations is $15.07 M

What is SpringWorks Therapeutics quarterly CFO year-on-year change?

Over the past year, SWTX quarterly cash flow from operations has changed by +$12.29 M (+29.41%)

What is SpringWorks Therapeutics TTM cash flow from operations?

The current TTM CFO of SWTX is -$175.60 M

What is the all time high TTM CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM cash flow from operations is -$7.18 M

What is SpringWorks Therapeutics TTM CFO year-on-year change?

Over the past year, SWTX TTM cash flow from operations has changed by +$58.29 M (+24.92%)